While quarfloxin was first considered to be a selective binder of MYC G4, its mechanism of action was later attributed to its preferential disruption of nucleolin binding to ribosomal G4 in the nucleolus, resulting in the inhibition of Pol I transcription and rRNA biogenesis and induced apoptosis in cancer cells [184]. This evidence concerns the gene MYC and cancer.